Clinical trials at the medicine branch of the NCI-part 2.
Cheson
B D
BD
National Cancer Institute.
Wilson
W H
WH
Phillips
P H
PH
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016543:Central Nervous System Neoplasms / Q000628:therapy; D002986:Clinical Trials as Topic; D005134:Eye Neoplasms / Q000628:therapy; D006801:Humans; D007167:Immunotherapy; D008223:Lymphoma / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy; D012008:Recurrence
D000970:Antineoplastic Agents; C080125:9-aminocamptothecin; D002166:Camptothecin